Biomarkers of DNA repair and related pathways: Significance in non-small cell lung cancer

Sacha I. Rothschild, Oliver Gautschi, Primo N Lara, Philip Mack, David R Gandara

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Purpose of review: To review selected biomarkers of DNA repair and related pathways as they relate to the management of patients with non-small cell lung cancer (NSCLC), emphasizing the role of individualized, chemotherapy for advanced disease, and discussing potential applications in early disease. Recent findings: The activity of molecular-targeted agents in NSCLC patients whose tumor possesses relevant biomarkers [such as epidermal growth factor receptor (EGFR) activating mutations and ALK translocations] has made personalized therapy possible. In addition, preclinical and clinical studies have shown that histopathological and biomolecular factors can correlate with clinical outcome in patients with NSCLC treated with chemotherapy. As a result, tumor histology is now routinely considered in selecting chemotherapy for NSCLC patients, such as pemetrexed for nonsquamous histology. Molecular tumor and host factors, including genes involved in DNA-repair and synthesis, are potentially even more relevant as predictive biomarkers of tumor response to chemotherapy. However, individual molecular markers and gene signatures need further validation and standardization, before routine use in the clinic can be recommended. Summary: In the era of molecular-targeted agents, individualized therapy based on molecular biomarkers has become a reality in the treatment of patients with advanced NSCLC. Further studies are needed to optimize current treatment algorithms with regard to biomarkers for chemotherapy benefit, to refine molecular markers, and to translate these findings to early stage NSCLC.

Original languageEnglish (US)
Pages (from-to)150-157
Number of pages8
JournalCurrent Opinion in Oncology
Volume23
Issue number2
DOIs
StatePublished - Mar 2011

Keywords

  • biomarker
  • chemotherapy
  • gene expression
  • lung cancer
  • personalized medicine

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Biomarkers of DNA repair and related pathways: Significance in non-small cell lung cancer'. Together they form a unique fingerprint.

  • Cite this